butantan

Small moleculeexperimental

The Instituto Butantan is a Brazilian biologic research center located in Butantã, in the western part of the city of São Paulo, Brazil. Instituto Butantan is a public institution affiliated with the São Paulo State Secretariat of Health and considered one of the major scientific centers in the world. Butantan is the largest immunobiologicals and biopharmaceuticals producer in Latin America. It is known for its collection of venomous snakes, as well as those of venomous lizards, spiders, insects and scorpions. By extracting the reptiles' and insects' venoms, the Institute develops antivenoms and medicines against many diseases, which include tuberculosis, rabies, tetanus and diphtheria. — Wikipedia

Clinical trial activity

2 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2005 (NCT02305160)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetSurfactant

    surfactant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • butantan

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05710224Phase 2Feb 15, 2023Butantan Institute, Merck
NCT02305160Phase 2/Phase 3 (Phase 3)Apr 1, 2005Government of Brazil, University of Sao Paulo
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Butantan InstituteAcademic/Hospital1112023
Government of BrazilGovernment1012005
MerckFor profit1012023
University of Sao PauloAcademic/Hospital1112005
4 organizations
Page 1 / 1